Autoregulation of Glomerular Filtration Rate in Patients with Diabetes

  • Per K. Christensen
  • Hans-Henrik Parving


The close relationship between elevated blood pressure and diabetic nephropathy are documented both in Type 1 and Type 2 diabetic patients. Approximately 75–85% of diabetic patients with nephropathy are hypertensive [1–3].


Glomerular Filtration Rate Diabetic Nephropathy Mean Arterial Blood Pressure Renal Plasma Flow Myogenic Response 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Mogensen CE, Christensen CK: Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 311:89–93, 1984PubMedCrossRefGoogle Scholar
  2. 2.
    Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T: Diabetic nephropathy in Type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia 25:496–501, 1983PubMedCrossRefGoogle Scholar
  3. 3.
    Tarnow L, Rossing P, Gall M-A, Nielsen FS, Parving H-H: Prevalence of arterial hypertension in diabetic patients before and after the JNC-V. Diabetes Care 17(11): 1247–1251, 1994PubMedCrossRefGoogle Scholar
  4. 4.
    Rossing P, Hommel E, Smidt UM, Parving H-H: Impact of arterial blood pressure and albuminuria on the progression of diabetic nephropathy in IDDM patients. Diabetes 42:715–719, 1993PubMedCrossRefGoogle Scholar
  5. 5.
    Parving H-H, Smidt UM, Hommel E, Mathiesen ER, Rossing P, Nielsen FS, Gall M-A: Effective Antihypertensive Treatment Postpones Renal Insufficiency in Diabetic Nephropathy. Am J Kidney Dis 22:188–195, 1993Google Scholar
  6. 6.
    Parving H-H, Rossing P, Hommel E, Smidt UM: Angiotensin converting enzyme inhibition in diabetic nephropathy: ten years experience. Am J Kidney Dis 26:99–107, 1995PubMedCrossRefGoogle Scholar
  7. 7.
    Björck S, Mulec H, Johnsen SA, Nordén G, Aurell M: Renal protective effect of enalapril in diabetic nephropathy. Br Med J 304:339–343, 1992CrossRefGoogle Scholar
  8. 8.
    Breyer JA, Bain P, Evans JK, Nahman NS, Lewis E, Cooper ME, McGill JB, Berl T, The Collaborative Study Group: Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy. Kidney Int 50:1651–1658, 1996PubMedCrossRefGoogle Scholar
  9. 9.
    Walker WG, Hermann J, Murphy RP, Russell RP: Prospective study of the impact of hypertension upon kidney function in diabetes mellitus. Nephron 55(suppl 1):21–26, 1990Google Scholar
  10. 10.
    Yokoyama H, Tomonaga O, Hirayama M, Ishii A, Takeda M, Babazono T, Ujihara U, Takahashi C, Omori Y: Predictors of the progression of diabetic nephropathy and the beneficial effect of angiotensin-converting enzyme inhibitors in NIDDM patients. Diabetologia 40:405–411, 1997PubMedCrossRefGoogle Scholar
  11. 11.
    Peterson JC, Adler S, Burkart JM, Green T, Herbert LA, Hunsicker LG, King AJ, Klahr S, Massry SG, Seifter JL: Blood pressure control, proteinuria, and the progression of renal disease. The modification of diet in renal disease study. Ann Intern Med 123:754–762, 1995PubMedCrossRefGoogle Scholar
  12. 12.
    Parving H-H, Andersen AR, Smidt UM, Hommel E, Mathiesen ER, Svendsen PA: Effect of antihypertensive treatment on kidney function in diabetic nephropathy. Br Med J 294:1443–1447, 1987CrossRefGoogle Scholar
  13. 13.
    Lebovitz HE, Wiegmann TB, Cnaan A, Shahinfar S, Sica D, Broadstone V, Schwartz SL, Mengel MC, Segal R, Versaggi JA, Bolten WK: Renal protective effects of enalapril in hypertensive NIDDM: Role of baseline albuminuria. Kidney Int 45(suppl. 45):S150–S155, 1994Google Scholar
  14. 14.
    Hansen HP, Rossing P, Tarnow L, Nielsen FS, Jensen BR, Pairing H-H:Increased glome-rular filtration rate after withdrawal of long-term antihypertensive treatment in diabetic nephropathy. Kidney Int 47:1726–1731, 1995PubMedCrossRefGoogle Scholar
  15. 15.
    Hansen HP, Nielsen FS, Rossing P, Jacobsen P, Jensen BR, Parving H-H: Kidney function after withdrawal of long-term antihypertensive treatment in diabetic nephropathy. Kidney Int 52:S49–S53, 1997Google Scholar
  16. 16.
    Anderson S: Relevance of single nephron studies to human glomerular function. Kidney Int 45:384–389, 1994PubMedCrossRefGoogle Scholar
  17. 17.
    Maddox DA, Brenner BM: Glomerular ultrafiltration, in The Kidney, edited by Brenner BM, Philidelphia, Saunders, 1996, p. 286Google Scholar
  18. 18.
    Dustin P: Arteriolar hyalinosis. Int Rev Exp Pathol 1:73–138, 1962Google Scholar
  19. 19.
    Østerby R, Gall M-A, Schmitz A, Nielsen FS, Nyberg G, Parving H-H: Glomerular structure and function in proteinuric Type 2 (non-insulin-dependent) diabetic patients. Diabetologia 36:1064–1070, 1993PubMedCrossRefGoogle Scholar
  20. 20.
    Wang X, Aukland K, Iversen BM: Acute effects of angiotensin II receptor antagonist on autoregulation of zonal glomerular filtration rate in renovascular hypertensive rats. Kidney Blood Pressure Research 20:225–232, 1997PubMedCrossRefGoogle Scholar
  21. 21.
    Iversen BM, Kvam FI, Mørkrid L, Sekse I, Ofstad J: Effect of cyclooxygenase inhibition on renal blood flow autoregulation in SHR. Am J Physiol 32:F534–F539, 1992Google Scholar
  22. 22.
    Pelayo JC, Westcott JY: Impaired autoregulation of glomerular capillary hydrostatic pressure in the rat remnant nephron. J Clin Invest 88:101–105, 1991PubMedCrossRefGoogle Scholar
  23. 23.
    Iversen BM, Kvam FI, Matre K, Ofstad J: Resetting of renal blood autoregulation during acute blood pressure reduction in hypertensive rats. Am J Physiol 44:R343–R349, 1998Google Scholar
  24. 24.
    Dworkin LD, Brenner BM: The renal circulations, in The Kidney, edited by Brenner BM, Philadelphia, Saunders, 1996, p. 247Google Scholar
  25. 25.
    Lush DJ, Fray JCS: Steady-state autoregulation of renal blood flow: a myogenic model. Am J Physiol 247:R89–R99, 1984PubMedGoogle Scholar
  26. 26.
    Aukland K, Oeien AH: Renal autoregulation: models combining tubuloglomerular feedback and myogenic response. Am J Physiol 252:F768–F783, 1987PubMedGoogle Scholar
  27. 27.
    Hayashi K, Epstein M, Loutzenhiser R: Determinants of the renal actions of atrial natriuretic peptide (ANP): lack of effect of ANP on pressure-induced vasocontriction. Circ Res 67:1–10, 1990PubMedCrossRefGoogle Scholar
  28. 28.
    Hayashi K, Epstein M, Loutzenhiser R: Pressure-induced vasocontriction of renal microvessels in normotensive and hypertensive rats: studies in the isolated perfused hydronephrotic kidney. Circ Res 65:1475–1484, 1989PubMedCrossRefGoogle Scholar
  29. 29.
    Hayashi K, Epstein M, Loutzenhiser R, Forster H: Impaired myogenic responsiveness of the afferent arteriole in streptozotocin-induced diabetic rats: Role of eicosanoid derangements. J Am Soc Nephrol 2:1578–1586, 1992PubMedGoogle Scholar
  30. 30.
    Hill GS, Heptinstall RH: Steorid-induced hypertension in the rat. Am J Pathol 52:1–39, 1968PubMedGoogle Scholar
  31. 31.
    Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM: Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 77:1925–1930, 1986PubMedCrossRefGoogle Scholar
  32. 32.
    Iversen BM, Ofstad J: Loss of renal blood flow autoregulation in chronic glomeru-lonephritic rats. Am J Physiol 254:F284–F290, 1988PubMedGoogle Scholar
  33. 33.
    Riser BL, Cortes P, Zhao X, Bernstein J, Dumler F, Narins RG: Intraglomerular pressure and mesangial stretchning stimulate extracellular matrix formation in the rat. J Clin Invest 90:1932–1943, 1992PubMedCrossRefGoogle Scholar
  34. 34.
    Kollros PR, Bates SR, Mathews MB, Horwitz AL, Glagov S: Cyclic AMP inhibits increased collagen production by cyclically stretched smooth muscle cells. Lab Invest 56:410–417, 1987PubMedGoogle Scholar
  35. 35.
    Mauer SM: Structural-functional correlations of diabetic nephropathy. Kidney Int 45:612–622, 1994PubMedCrossRefGoogle Scholar
  36. 36.
    Griffin KA, Picken MM, Bidani AK: Method of renal mass reduction is a critical modulator of subsequent hypertension and glomerular injury. J Am Soc Nephrol 4:2023–2031, 1994PubMedGoogle Scholar
  37. 37.
    Bidani AK, Schwartz M, Lewis E: Renal autoregulation and vulnerability to hypertensive injury in remnant kidney. Am J Physiol 252:F1003–F1010, 1987PubMedGoogle Scholar
  38. 38.
    Christensen PK, Hommel E, Clausen P, Feldt-Rasmussen B, Parving H-H: Impaired autoregulation of the glomerular filtration rate in patients with nondiabetic nephropathies. Kidney Int 56:1517–1523, 1999PubMedCrossRefGoogle Scholar
  39. 39.
    Hostetter TH, Rennke HG, Brenner BM: The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med 72:375–380, 1982PubMedCrossRefGoogle Scholar
  40. 40.
    Hashimoto Y, Ideura Y, Yoshimura A, Koshikawa S: Autoregulation of renal blood flow in streptozocin-induced diabetic rats. Diabetes 38:1109–1113, 1989PubMedCrossRefGoogle Scholar
  41. 41.
    Tolins JP, Shultz PJ, Raij L, Brown DM, Mauer M: Abnormal renal hemodynamic response to reduced renal perfusion pressure in diabetic rats: role of NO. Am J Physiol 265:F866–F895, 1993Google Scholar
  42. 42.
    Parving H-H, Kastrup J, Smidt Urn, Andersen AR, Feldt-Rasmussen B, Christiansen JS: Impaired autoregulation of glomerular filtration rate in Type 1 (insulin-dependent) diabetic patients with nephropathy. Diabetologia 27:547–552, 1984PubMedCrossRefGoogle Scholar
  43. 43.
    Brod J, Horbach L, Just H, Rosenthal J, Nicolescu R: Acute effects of clonidine on central and peripheral haemodynamics and plasma renin activity. Eur J Clin Pharm 4:107–114, 1972CrossRefGoogle Scholar
  44. 44.
    Onesti G, Bock KD, Heimsoth V, Kim KE, Merguet P: Clonidine: a new antihypertensive agent. Am J Cardiol 28:74–83, 1971PubMedCrossRefGoogle Scholar
  45. 45.
    Onesti G, Schwartz AB, Kim KE, Pas-Martinez V, Swartz C: Antihypertensive effect of clonidine. Circ Res 28:53–69, 1971Google Scholar
  46. 46.
    Christensen PK, Hansen HP, Parving H-H: Impaired autoregulation of GFR in hypertensive non-insulin dependent diabetic patients. Kidney Int 52:1369–1374, 1997PubMedCrossRefGoogle Scholar
  47. 47.
    Griffin KA, Picken MM, Bidani AK: Deleterious effects of calcium channel blockade on pressure transmission and glomerular injury in rat remnant kidneys. J Clin Invest 96:793–800, 1995PubMedCrossRefGoogle Scholar
  48. 48.
    Apperloo AJ, De Zeeuw D, De Jong PE: A short-term antihypertensive treatment-induced fall in glomerular filtration rate predicts long-term stability of renal function. Kidney Int 51:793–797, 1997PubMedCrossRefGoogle Scholar
  49. 49.
    Klahr S: The modification of diet in renal disease study. N Engl J Med 320:864–866, 1989PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2000

Authors and Affiliations

  • Per K. Christensen
    • 1
  • Hans-Henrik Parving
    • 1
  1. 1.Steno Diabetes CenterGentofteDenmark

Personalised recommendations